Literature DB >> 13618646

Cortisone and corticotrophin in ulcerative colitis.

S C TRUELOVE, L J WITTS.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; COLITIS, ULCERATIVE/therapy; CORTISONE/therapeutic use

Mesh：

Substances：

Year:  1959        PMID： 13618646      PMCID： PMC1992572          DOI： 10.1136/bmj.1.5119.387

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  9 in total

1.  Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium; a report on a controlled therapeutic trial.

Authors:  S C TRUELOVE; M H HAMBLING
Journal:  Br Med J       Date:  1958-11-01

2.  Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; a controlled trial employing restricted sequential analysis.

Authors:  G WATKINSON
Journal:  Br Med J       Date:  1958-11-01

3.  Corticosteroid therapy in chronic ulcerative colitis.

Authors:  S M FIERST; E ROBINSON; A LANGSAM; A WERNER; A P INGEGNO
Journal:  J Am Med Assoc       Date:  1957-04-20

4.  The treatment of ulcerative colitis.

Authors:  J B KIRSNER; R O BICKS; W L PALMER
Journal:  AMA Arch Intern Med       Date:  1957-04

5.  The use of ACTH and cortisone in idiopathic ulcerative colitis.

Authors:  E J MALTBY; R C DICKSON; P M O'SULLIVAN
Journal:  Can Med Assoc J       Date:  1956-01-01       Impact factor: 8.262

6.  The use of ACTH, cortisone, hydrocortisone and related compounds in the management of ulcerative colitis; experience in 180 patients.

Authors:  J B KIRSNER; M SKLAR; W L PALMER
Journal:  Am J Med       Date:  1957-02       Impact factor: 4.965

7.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

8.  Problems in the management of ulcerative colitis, with particular reference to ACTH and the adrenal steroids.

Authors:  J B KIRSNER; W L PALMER; M SKLAR
Journal:  Ann Intern Med       Date:  1957-01       Impact factor: 25.391

9.  Ulcerative colitis; therapeutic effects of corticotropin (ACTH) and cortisone in 120 patients.

Authors:  J B KIRSNER; W L PALMER
Journal:  Ann Intern Med       Date:  1954-08       Impact factor: 25.391
  9 in total
  44 in total

1.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part II.

Authors:  R G Shorter; D A Shephard
Journal:  Am J Dig Dis       Date:  1975-07

Review 2.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

3.  STEROID ADDICTION IN ULCERATIVE COLITIS.

Authors:  M KELLY
Journal:  Br Med J       Date:  1964-12-12

Review 4.  THE CONTROLLED THERAPEUTIC TRIAL IN GASTROENTEROLOGY.

Authors:  S C TRUELOVE; R WRIGHT
Journal:  Am J Dig Dis       Date:  1964-01

5.  Clinical and pathologic observations in steroid-treated ulcerative colitis.

Authors:  H M SPIRO
Journal:  Am J Dig Dis       Date:  1960-06

6.  Some notes on the epidemiology of nonspecific ulcerative colitis. An apparent increase in incidence in Jews.

Authors:  H A WEINER; C M LEWIS
Journal:  Am J Dig Dis       Date:  1960-05

7.  Ulcerative colitis provoked by milk.

Authors:  S C TRUELOVE
Journal:  Br Med J       Date:  1961-01-21

8.  Factors in the pathogenesis of peptic ulcer. The present basis of treatment.

Authors:  J E LENNARD-JONES
Journal:  Postgrad Med J       Date:  1960-12       Impact factor: 2.401

9.  Infiltration of CD19+ plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis.

Authors:  Yoshio Jinno; Haruo Ohtani; Shiro Nakamura; Motoji Oki; Kiyoshi Maeda; Kohei Fukushima; Hiroshi Nagura; Nobuhide Oshitani; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Virchows Arch       Date:  2006-01-25       Impact factor: 4.064

10.  Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease.

Authors:  K Sawada; K Ohnishi; S Fukui; K Yamada; M Yamamura; K Amano; K Amano; M Wada; N Tanida; M Satomi
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.